329 related articles for article (PubMed ID: 33141208)
1. Association Between Industry Payments to Physicians and Device Selection in ICD Implantation.
Annapureddy AR; Henien S; Wang Y; Minges KE; Ross JS; Spatz ES; Desai NR; Peterson PN; Masoudi FA; Curtis JP
JAMA; 2020 Nov; 324(17):1755-1764. PubMed ID: 33141208
[TBL] [Abstract][Full Text] [Related]
2. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
Marzec LN; Peterson PN; Bao H; Curtis JP; Masoudi FA; Varosy PD; Bradley SM
JAMA Cardiol; 2017 May; 2(5):561-565. PubMed ID: 28122073
[TBL] [Abstract][Full Text] [Related]
3. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
[TBL] [Abstract][Full Text] [Related]
4. Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians' survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry.
Biffi M; Menardi E; Narducci ML; Ammendola E; Messano L; Giofrè F; Baiocchi C; Saporito D; Lissoni F; Bertini M; Pierantozzi A; Zingarini G; Malacrida M; Ziacchi M
J Cardiovasc Med (Hagerstown); 2017 Dec; 18(12):968-975. PubMed ID: 29028784
[TBL] [Abstract][Full Text] [Related]
5. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.
Curtis JP; Luebbert JJ; Wang Y; Rathore SS; Chen J; Heidenreich PA; Hammill SC; Lampert RI; Krumholz HM
JAMA; 2009 Apr; 301(16):1661-70. PubMed ID: 19383957
[TBL] [Abstract][Full Text] [Related]
6. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
8. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
[TBL] [Abstract][Full Text] [Related]
9. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of elderly patients treated with an implantable cardioverter-defibrillator or cardiac resynchronization therapy in a real-world setting: data from the Israeli ICD Registry.
Suleiman M; Goldenberg I; Haim M; Schliamser JE; Boulos M; Ilan M; Swissa M; Gavrielov-Yusim N; Fuchs T; Amit G; Glikson M;
Heart Rhythm; 2014 Mar; 11(3):435-41. PubMed ID: 24315966
[TBL] [Abstract][Full Text] [Related]
11. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.
Landolina M; Morani G; Curnis A; Vado A; D'Onofrio A; Bianchi V; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
Europace; 2017 Aug; 19(8):1349-1356. PubMed ID: 27702861
[TBL] [Abstract][Full Text] [Related]
13. Multi-Center, Community-Based Cardiac Implantable Electronic Devices Registry: Population, Device Utilization, and Outcomes.
Gupta N; Kiley ML; Anthony F; Young C; Brar S; Kwaku K
J Am Heart Assoc; 2016 Mar; 5(3):e002798. PubMed ID: 26961369
[TBL] [Abstract][Full Text] [Related]
14. Association of body mass index with cardiac resynchronization therapy intention and left ventricular lead implantation failure: insights from the NCDR implantable cardioverter-defibrillator registry.
Nishimura M; Marcus GM; Varosy PD; Bao H; Wang Y; Curtis JP; Hsu JC
J Interv Card Electrophysiol; 2020 Mar; 57(2):279-288. PubMed ID: 31004224
[TBL] [Abstract][Full Text] [Related]
15. Association of Compensation From the Surgical and Medical Device Industry to Physicians and Self-declared Conflict of Interest.
Ziai K; Pigazzi A; Smith BR; Nouri-Nikbakht R; Nepomuceno H; Carmichael JC; Mills S; Stamos MJ; Jafari MD
JAMA Surg; 2018 Nov; 153(11):997-1002. PubMed ID: 30140910
[TBL] [Abstract][Full Text] [Related]
16. Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?
Hess PL; Mi X; Curtis LH; Wilkoff BL; Hegland DD; Al-Khatib SM
Heart Rhythm; 2013 Aug; 10(8):1127-33. PubMed ID: 23773989
[TBL] [Abstract][Full Text] [Related]
17. An analysis of implantable cardiac device reliability. The case for improved postmarketing risk assessment and surveillance.
Laskey W; Awad K; Lum J; Skodacek K; Zimmerman B; Selzman K; Zuckerman B
Am J Ther; 2012 Jul; 19(4):248-54. PubMed ID: 22668602
[TBL] [Abstract][Full Text] [Related]
18. Variation in regional implantation patterns of cardiac implantable electronic device in Switzerland.
Bolt L; Wertli MM; Haynes AG; Rodondi N; Chiolero A; Panczak R; Aujesky D
PLoS One; 2022; 17(2):e0262959. PubMed ID: 35171922
[TBL] [Abstract][Full Text] [Related]
19. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
Jędrzejczyk-Patej E; Mazurek M; Kotalczyk A; Kowalska W; Konieczny-Kozielska A; Kozielski J; Podolecki T; Szulik M; Sokal A; Kowalski O; Kalarus Z; Średniawa B; Lenarczyk R
Europace; 2021 Jan; 23(1):113-122. PubMed ID: 33257952
[TBL] [Abstract][Full Text] [Related]
20. Impact of diabetes on clinical outcome of patients with heart failure undergoing ICD and CRT procedures: results from the German Device Registry.
Kaya E; Senges J; Hochadel M; Eckardt L; Andresen D; Ince H; Spitzer SG; Kleemann T; Maier SSK; Jung W; Stellbrink C; Rassaf T; Wakili R
ESC Heart Fail; 2020 Jun; 7(3):984-995. PubMed ID: 32068978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
